Payam Nahid, MD, MPH, has been appointed as associate director, Clinical Trials Operations (CTO), in the Office of Research after a competitive internal UCSF search. In his new role, Dr. Nahid will collaborate closely with the associate vice chancellor of Clinical Research and the rest of the Office of Research leadership.
Dr. Nahid’s focus will be on optimizing clinical trial operations for UCSF investigators across all four schools and multiple UCSF campus sites. He will work directly with UCSF research faculty and staff and other relevant campus stakeholders to identify and address the key areas needing improvement. Dr. Nahid will also serve a leadership role in the Clinical and Translational Science Institute, directing its Trial Innovation Network (TIN) program that supports and enables multicenter clinical trials. While the focus of Dr. Nahid's attention will be on clinical trials, it is expected that his efforts will benefit the broader scope of clinical research activities at UCSF.
Dr. Nahid is a professor of medicine with the Division of Pulmonary and Critical Care Medicine at Zuckerberg San Francisco General Hospital and Trauma Center and has been on the faculty since 2004. His specialty is tuberculosis (TB) research, conducting CDC- and NIH-sponsored clinical trials and translational research in the U.S. and Vietnam, including co-chairing an ongoing FDA-registration trial conducted through the CDC-TB Trials Consortium and the National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. With expertise in policy, Dr. Nahid has served as chair of the WHO Task Force on the Development of Policies for Introduction of New TB Drugs and Treatment Regimens; WHO technical consultation on advances in clinical trials; and U.S. CDC practice guidelines for the treatment of TB. He is a guest editor of a special collection on advances in TB clinical trials in PLOS Medicine being published this year.